Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 17

1.

Pharmacokinetic assessment of 18F-(2S,4R)-4-fluoroglutamine in patients with cancer.

Grkovski M, Goel R, Krebs S, Staton KD, Harding JJ, Mellinghoff IK, Humm JL, Dunphy MP.

J Nucl Med. 2019 Oct 10. pii: jnumed.119.229740. doi: 10.2967/jnumed.119.229740. [Epub ahead of print]

PMID:
31601700
2.

Biodistribution and Dosimetry of Intraventricularly Administered 124I-Omburtamab in Patients with Metastatic Leptomeningeal Tumors.

Pandit-Taskar N, Zanzonico PB, Kramer K, Grkovski M, Fung EK, Shi W, Zhang Z, Lyashchenko SK, Fung AM, Pentlow KS, Carrasquillo JA, Lewis JS, Larson SM, Cheung NV, Humm JL.

J Nucl Med. 2019 Dec;60(12):1794-1801. doi: 10.2967/jnumed.118.219576. Epub 2019 Aug 12.

PMID:
31405921
3.

18F-fluoromisonidazole predicts evofosfamide uptake in pancreatic tumor model.

Grkovski M, Fanchon L, Pillarsetty NVK, Russell J, Humm JL.

EJNMMI Res. 2018 Jun 18;8(1):53. doi: 10.1186/s13550-018-0409-1.

4.

11C-Choline Pharmacokinetics in Recurrent Prostate Cancer.

Grkovski M, Gharzeddine K, Sawan P, Schöder H, Michaud L, Weber WA, Humm JL.

J Nucl Med. 2018 Nov;59(11):1672-1678. doi: 10.2967/jnumed.118.210088. Epub 2018 Apr 6.

5.

Inter-operator variability in compartmental kinetic analysis of 18F-fluoromisonidazole dynamic PET.

Nehmeh SA, Schwartz J, Grkovski M, Yeung I, Laymon CM, Muzi M, Humm JL.

Clin Imaging. 2018 May - Jun;49:121-127. doi: 10.1016/j.clinimag.2017.12.015. Epub 2018 Jan 12.

6.

Predicting hypoxia status using a combination of contrast-enhanced computed tomography and [18F]-Fluorodeoxyglucose positron emission tomography radiomics features.

Crispin-Ortuzar M, Apte A, Grkovski M, Oh JH, Lee NY, Schöder H, Humm JL, Deasy JO.

Radiother Oncol. 2018 Apr;127(1):36-42. doi: 10.1016/j.radonc.2017.11.025. Epub 2017 Dec 19.

7.

Experimental evaluation of the resolution improvement provided by a silicon PET probe.

Brzeziński K, Oliver JF, Gillam J, Rafecas M, Studen A, Grkovski M, Kagan H, Smith S, Llosá G, Lacasta C, Clinthorne NH.

J Instrum. 2016 Sep;11. pii: P09016. Epub 2016 Sep 30.

8.

Predictive modeling of outcomes following definitive chemoradiotherapy for oropharyngeal cancer based on FDG-PET image characteristics.

Folkert MR, Setton J, Apte AP, Grkovski M, Young RJ, Schöder H, Thorstad WL, Lee NY, Deasy JO, Oh JH.

Phys Med Biol. 2017 Jul 7;62(13):5327-5343. doi: 10.1088/1361-6560/aa73cc. Epub 2017 Jun 12.

9.

Monitoring early response to chemoradiotherapy with 18F-FMISO dynamic PET in head and neck cancer.

Grkovski M, Lee NY, Schöder H, Carlin SD, Beattie BJ, Riaz N, Leeman JE, O'Donoghue JA, Humm JL.

Eur J Nucl Med Mol Imaging. 2017 Sep;44(10):1682-1691. doi: 10.1007/s00259-017-3720-6. Epub 2017 May 24.

10.

18F-Fluoromisonidazole Kinetic Modeling for Characterization of Tumor Perfusion and Hypoxia in Response to Antiangiogenic Therapy.

Grkovski M, Emmas SA, Carlin SD.

J Nucl Med. 2017 Oct;58(10):1567-1573. doi: 10.2967/jnumed.117.190892. Epub 2017 Mar 30.

11.

Pharmacokinetic Analysis of Dynamic 18F-Fluoromisonidazole PET Data in Non-Small Cell Lung Cancer.

Schwartz J, Grkovski M, Rimner A, Schöder H, Zanzonico PB, Carlin SD, Staton KD, Humm JL, Nehmeh SA.

J Nucl Med. 2017 Jun;58(6):911-919. doi: 10.2967/jnumed.116.180422. Epub 2017 Feb 23.

12.

Multi-site quality and variability analysis of 3D FDG PET segmentations based on phantom and clinical image data.

Beichel RR, Smith BJ, Bauer C, Ulrich EJ, Ahmadvand P, Budzevich MM, Gillies RJ, Goldgof D, Grkovski M, Hamarneh G, Huang Q, Kinahan PE, Laymon CM, Mountz JM, Muzi JP, Muzi M, Nehmeh S, Oborski MJ, Tan Y, Zhao B, Sunderland JJ, Buatti JM.

Med Phys. 2017 Feb;44(2):479-496. doi: 10.1002/mp.12041.

13.

Multiparametric Imaging of Tumor Hypoxia and Perfusion with 18F-Fluoromisonidazole Dynamic PET in Head and Neck Cancer.

Grkovski M, Schöder H, Lee NY, Carlin SD, Beattie BJ, Riaz N, Leeman JE, O'Donoghue JA, Humm JL.

J Nucl Med. 2017 Jul;58(7):1072-1080. doi: 10.2967/jnumed.116.188649. Epub 2017 Feb 9.

14.

Reproducibility of 18F-fluoromisonidazole intratumour distribution in non-small cell lung cancer.

Grkovski M, Schwartz J, Rimner A, Schöder H, Carlin SD, Zanzonico PB, Humm JL, Nehmeh SA.

EJNMMI Res. 2016 Dec;6(1):79. Epub 2016 Nov 7.

15.

Feasibility of 18F-Fluoromisonidazole Kinetic Modeling in Head and Neck Cancer Using Shortened Acquisition Times.

Grkovski M, Schwartz J, Gönen M, Schöder H, Lee NY, Carlin SD, Zanzonico PB, Humm JL, Nehmeh SA.

J Nucl Med. 2016 Mar;57(3):334-41. doi: 10.2967/jnumed.115.160168. Epub 2015 Nov 25.

16.

Silicon detectors for combined MR-PET and MR-SPECT imaging.

Studen A, Chesi E, Cindro V, Clinthorne NH, Cochran E, Grošičar B, Grkovski M, Honscheid K, Kagan H, Lacasta C, Llosa G, Mikuž M, Stankova V, Weilhammer P, Zontar D.

Nucl Instrum Methods Phys Res A. 2013 Feb 21;702:88-90. Epub 2012 Sep 1.

17.

Silicon as an Unconventional Detector in Positron Emission Tomography.

Clinthorne NH, Brzezinski K, Chesi E, Cochran E, Grkovski M, Grošičar B, Honscheid K, Huh S, Kagan H, Lacasta C, Linhart V, Mikuž M, Smith S, Stankova V, Studen A, Weilhammer P, Zontar D.

Nucl Instrum Methods Phys Res A. 2013 Jan 1;699(21):216-220. Epub 2012 May 14.

Supplemental Content

Loading ...
Support Center